MCTP was formed in 2007, under the directorship of Dr. Arul Chinnaiyan,
as a focused initiative to bring basic research discoveries from
molecular medicine to clinical applications for the identification of
biomarkers and therapeutic targets for cancer diagnosis and treatment.
MCTP resources include core laboratories in proteomics, microarray, and
immunomics, as well as an extensive bioinformatics infrastructure.
under the Center umbrella is the Molecular Testing Laboratory (MTL).
MTL provides service to meet the medical needs of the University of
Michigan Health System and the clients of the M-Labs program. The MTL is
fully accredited by Clinical Laboratory Improvement Amendment and
College of American Pathologists and is active in the CAP Laboratory
Accreditation and Proficiency Testing programs. MTL currently offers PCA3 and CTC
diagnostic testing and several other tests are in development.
We've recently undertaken a new initiative, MI-ONCOSEQ, to exploit the rapid advances in DNA sequencing technologies to realize the goals of “personalized medicine”
for the treatment of cancer. MI-ONCOSEQ
project brings together expertise at the University of Michigan
including clinical oncology, clinical genetics, genomic
science/bioinformatics, clinical pathology, social and behavioral
sciences, and bioethics in order to implement the practice of
personalized medicine in cancer treatment. This project will also
address some of the major ethical challenges that accompany genetic
You can read more about the tests available by visiting MTL and MI-ONCOSEQ webpages.